Showing Results for
- Academic Journals (12)
Search Results
- 12
Academic Journals
- 12
- Search Terms:
- 1From: Pharmacogenomics. (Vol. 11, Issue 11) Peer-ReviewedAuthor(s): Nadine Darwiche [[dagger]] 1 , Marwan El-Sabban 2 Evaluation of: Sertel S, Eichhorn T, Sieber S et al. : Factors determining sensitivity or resistance of tumor cell lines towards artesunate. Chem. Biol....
- 2From: Pharmacogenomics. (Vol. 11, Issue 11) Peer-ReviewedAuthor(s): Rebecca L Roberts [[dagger]] 1 , Richard B Gearry 2 , Murray L Barclay 3 KEYWORDS : 6-mercaptopurine; 6-TGN; aldehyde oxidase; azathioprine; GMPS; IMPDH; preferential 6-MMP metabolism; thiopurine;...
- 3From: Pharmacogenomics. (Vol. 11, Issue 11) Peer-ReviewedAuthor(s): Sandeep Grover 1 , Puneet Talwar 1 , Mandaville Gourie-Devi 2 , Meenal Gupta 1 , Kiran Bala 2 , Sangeeta Sharma 2 , Ruchi Baghel 1 , Harpreet Kaur 1 , Abhay Sharma 1 , Ritushree Kukreti [[dagger]] 3...
- 4From: Pharmacogenomics. (Vol. 11, Issue 11) Peer-ReviewedAuthor(s): Francisco Jesús Morón 1 , Agustín Ruiz [[dagger]] 2 KEYWORDS : controlled ovarian hyperstimulation; N680S; ovary; pharmacogenetics; recombinant follicle-stimulating hormone In recent years, the...
- 5From: Pharmacogenomics. (Vol. 11, Issue 11) Peer-ReviewedAuthor(s): Michelle N Sicard 1 , Clement C Zai 1 , Arun K Tiwari 1 , Renan P Souza 1 , Herbert Y Meltzer 2 , Jeffrey A Lieberman 3 , James L Kennedy 1 , Daniel J Müller [[dagger]] 4 KEYWORDS : 5-HT2C receptor;...
- 6From: Pharmacogenomics. (Vol. 11, Issue 11) Peer-Reviewed
CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine
Author(s): Keh-Ming Lin 1 , Hsiao-Hui Tsou 2 , I-Ju Tsai 3 , Mei-Chun Hsiao 4 , Chin-Fu Hsiao 5 , Chia-Yih Liu 6 , Winston W Shen 7 , Hwa-Sheng Tang 8 , Chun-Kai Fang 9 , Chi-Shin Wu 10 , Shao-Chun Lu 11 , Hsiang-Wei... - 7From: Pharmacogenomics. (Vol. 11, Issue 11) Peer-ReviewedAuthor(s): Stephen Matteson 1 , Joseph Paulauskis 2 , Sheldon Foisy 3 , Stephanie Hall 4 , Manuel Duval [[dagger]] 5 KEYWORDS : audit trail; drug development; LIMS; pharmacogenomics; transactional system The...
- 8From: Pharmacogenomics. (Vol. 11, Issue 11) Peer-ReviewedAuthor(s): Mara L Becker [[dagger]] 2 , J Steven Leeder 1 KEYWORDS : adverse drug reactions; genetic variants; methotrexate; pediatrics; pharmacogenomics Adverse drug reactions (ADRs) remain an ever present...
- 9From: Pharmacogenomics. (Vol. 11, Issue 11) Peer-ReviewedThe first signature gene capable of predicting cisplatin/vinorelbine treatment efficacy in non-small-cell lung cancer patients discovered. A collaborative study between the Princess Margaret Hospital (ON, Canada) and...
- 10From: Pharmacogenomics. (Vol. 11, Issue 11) Peer-ReviewedAuthor(s): Jesse J Swen 1 , Judith AM Wessels 1 , Annemarie Krabben 1 , Willem JJ Assendelft 2 , Henk-Jan Guchelaar [[dagger]] 3 KEYWORDS : CYP2C9 ; glibenclamide; gliclazide; glimepiride; pharmacogenetics;...
- 11From: Pharmacogenomics. (Vol. 11, Issue 11) Peer-ReviewedCitation Only
- 12From: Pharmacogenomics. (Vol. 11, Issue 11) Peer-ReviewedAuthor(s): Berta Almoguera 1 , Rosa Riveiro-Alvarez 2 , Belen Gomez-Dominguez 3 , Rosario Lopez-Rodriguez 4 , Pedro Dorado 5 , Concepción Vaquero-Lorenzo 6 , Rafael Dal-Ré 7 , Jose Fernandez-Piqueras 8 , Adrián LLerena...